Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase C zeta is an atypical member of the protein kinase C family encoded by the PRKCZ gene. Unlike classical PKCs that require calcium and diacylglycerol for activation, PKCζ operates independently of these cofactors but depends on phosphatidylserine. It plays critical roles in signal transduction pathways regulating cell proliferation, differentiation, secretion, apoptosis, and especially insulin-stimulated glucose transport. In neurons, an alternative transcript called protein kinase M zeta (PKMζ) is constitutively active and implicated in long-term memory maintenance. Structurally distinct from other isoforms due to only one zinc finger module and unique regulatory features, PKCζ interacts with proteins such as ZIP to mediate diverse cellular responses. Dysregulation has been linked to cancer progression and metabolic diseases.
Drugs targeting this molecule would likely act as kinase inhibitors—blocking its serine/threonine phosphorylation activity and thus modulating downstream signaling pathways involved in cell growth, survival, and metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C zeta (PKCζ).